Milestone PharmaceuticalsMIST
13F holders, Q3 2024 (September 30)At the end of Q3 2024, 43 institutions reported holding Milestone Pharmaceuticals Inc. (MIST) in their 13F filings, up 3 from Q2 2024. 4 opened new positions and 1 sold out. The largest holders were BlackRock, Inc. ($7.6M), RTW Investments, LP ($4.9M) and Millennium Management ($4.2M). 2 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Milestone Pharmaceuticals Inc.
- CUSIP
- 59935V107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $99K |
| Exits | 1 | $258 |
All 13F filers, Q2 2024 → Q3 2024: 259,277 shares bought and 1,760,309 shares sold, net −1,501,032 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 43 holders
| BlackRock, Inc. | 0.00% | — | 4,971,344 | $7.6M |
| RTW Investments, LP | 0.07% | No change | 3,256,102 | $4.9M |
| Millennium Management | 0.00% | Add +1.0% | 2,778,525 | $4.2M |
| Alta Fundamental Advisers LLC | 1.68% | No change | 2,658,589 | $4.0M |
| Citadel Advisors | 0.00% | Reduce -4.0% | 2,061,522 | $3.1M |
| Orbimed Advisors LLC | 0.06% | No change | 2,000,000 | $3.0M |
| Nantahala Capital Management, LLC | 0.22% | No change | 1,750,000 | $2.7M |
| Lion Point Capital, LP | 10.09% | Reduce -29.3% | 1,654,154 | $2.5M |
| Goldman Sachs Group Inc. | 0.00% | No change | 1,353,067 | $2.1M |
| Bleichroeder LP | 0.54% | No change | 1,326,085 | $2.0M |
| BML Capital Management, LLC | 1.02% | Add +3.0% | 1,136,091 | $1.7M |
| Stonepine Capital Management, LLC | 0.96% | Reduce -19.3% | 999,790 | $1.5M |
| Morgan Stanley | 0.00% | Add +10.8% | 918,312 | $1.4M |
| Ikarian Capital, LLC | 0.22% | No change | 466,019 | $708K |
| Altium Capital Management LLC | 0.20% | Reduce -56.5% | 440,000 | $669K |
| Boxer Capital, LLC | 0.02% | No change | 309,007 | $470K |
| Envestnet Asset Management Inc. | 0.00% | Add +18.6% | 70,590 | $107K |
| Ancora Advisors LLC | 0.00% | No change | 60,000 | $91K |
| Squarepoint Ops LLC | 0.00% | Reduce -0.8% | 54,245 | $82K |
| Atria Investments, Inc | 0.00% | Add +44.4% | 40,421 | $61K |
| Dimensional Fund Advisors LP | 0.00% | No change | 39,450 | $60K |
| Boothbay Fund Management, LLC | 0.00% | No change | 30,779 | $47K |
| PVG Asset Management Corp. | 0.19% | New | 30,345 | $46K |
| BNP Paribas Financial Markets | 0.00% | Add +18.7% | 29,209 | $44K |
| ADAR1 Capital Management, LLC | 0.01% | Reduce -86.2% | 27,931 | $42K |
| Northern Trust Corp. | 0.00% | Reduce -1.6% | 27,336 | $42K |
| Cetera Investment Advisers | 0.00% | Add +19.3% | 24,671 | $38K |
| Two Sigma Securities, LLC | 0.00% | New | 23,133 | $35K |
| Valeo Financial Advisors, LLC | 0.00% | Add +100.0% | 20,000 | $30K |
| Clear Creek Financial Management, LLC | 0.00% | No change | 19,500 | $30K |
| State Street Corp. | 0.00% | Add +2.0% | 19,311 | $29K |
| Geode Capital Management, LLC | 0.00% | No change | 17,576 | $27K |
| Beta Wealth Group, Inc. | 0.01% | No change | 14,127 | $21K |
| Creative Planning | 0.00% | No change | 13,080 | $20K |
| Engineers Gate Manager LP | 0.00% | New | 11,074 | $17K |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 10,500 | $16K |
| National Bank of Canada | 0.00% | No change | 7,100 | $11K |
| Osaic Holdings, Inc. | 0.00% | No change | 6,500 | $10K |
| Jones Financial Companies LLLP | 0.00% | Reduce -6.5% | 1,000 | $2K |
| Royal Bank of Canada | 0.00% | New | 800 | $1K |
| Barclays PLC | 0.00% | No change | 100 | $152 |
| Oliver Lagore Vanvalin Investment Group | 0.00% | No change | 100 | $152 |
| Simplex Trading, LLC | 0.00% | Reduce -82.0% | 214 | $0 |
"% of holder's portfolio" is MIST's weight in each manager's 13F, not the share of Milestone Pharmaceuticals Inc. the manager owns.